MPX International Opens Premium Holyweed CBD Flagship Retail Store in Geneva
TORONTO, Feb. 10, 2020 (GLOBE NEWSWIRE) — MPX International Corporation (“MPX International,” “MPXI” or the “Company”) (CSE:MPXI;OTC:MPXOF) announced the opening of […]
Trigon Mining (Namibia) Awarded New Exclusive Prospecting Licence
TORONTO, Feb. 10, 2020 (GLOBE NEWSWIRE) — Trigon Metals Inc. (TSX-V: TM) (“Trigon” or the “Company”) is pleased to announce […]
AIDEA Bolsters Support for Heavy REE Separation Plant & Renews Commitment to Ucore’s Bokan Heavy REE Project
HALIFAX, Nova Scotia, Feb. 10, 2020 (GLOBE NEWSWIRE) — Ucore Rare Metals Inc. (TSXV: UCU) (OTCQX: UURAF) (“Ucore” or the […]
PURE GLOBAL ANNOUNCES MORTGAGE FINANCING AND NON-BROKERED PRIVATE PLACEMENT
TORONTO, Feb. 10, 2020 (GLOBE NEWSWIRE) — Pure Global Cannabis Inc. (TSX.V:PURE; OTC: PRCNF) (the “Company” or “Pure Global” or […]
RigNet Signs Long-Term Agreement with Northern Offshore
HOUSTON, Feb. 10, 2020 (GLOBE NEWSWIRE) — RigNet (NASDAQ: RNET, the “Company”), the leading provider of ultra-secure, intelligent networking solutions, […]
Daseke Names Chris Easter as Permanent CEO
ADDISON, Texas, Feb. 10, 2020 (GLOBE NEWSWIRE) — Daseke, Inc. (NASDAQ: DSKE) (“Daseke” or the “Company”), the largest flatbed, specialized […]
National Vision Holdings, Inc. Announces Fourth Quarter 2019 Earnings Release and Conference Call
DULUTH, Ga., Feb. 10, 2020 (GLOBE NEWSWIRE) — National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will […]
Mitek Sets New Identity Verification Standard With One Step Liveness Detection
SAN DIEGO, Feb. 10, 2020 (GLOBE NEWSWIRE) — Mitek (NASDAQ: MITK, www.miteksystems.com), a global leader in digital identity verification solutions, […]
Salarius Pharmaceuticals to Present at the Noble Capital Markets’ 16th Annual Small & Microcap Investor Conference
HOUSTON, Feb. 10, 2020 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biotechnology company targeting cancers caused by […]
Arbutus Announces Decision to Discontinue AB-452 and to Pursue Development of a Next Generation HBV Specific Oral RNA-Destabilizer
Arbutus expects to announce AB-729 Preliminary Phase 1a/1b Data late Q12020WARMINSTER, Pa., Feb. 10, 2020 (GLOBE NEWSWIRE) — Arbutus Biopharma […]
